Control of latent/persistent HIV-1 infection in macrophages/microglia: A key role for the phosphatase PPM1A

控制巨噬细胞/小胶质细胞中潜伏/持续的 HIV-1 感染:磷酸酶 PPM1A 的关键作用

基本信息

  • 批准号:
    10447757
  • 负责人:
  • 金额:
    $ 18.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Persistent HIV-1 infection in cells of the monocyte/macrophage lineage in tissues such as the brain, gut, lymphoid tissues, or adipose tissue forms an under-investigated viral reservoirs that will prevent eradication of HIV-1, even if the reservoir in CD4+ T cells could be addressed. However, other than for latently HIV-1 infected T cells, so far the biomolecular control of latency in myeloid cells has not been detailed. We demonstrate that latently HIV- 1 infected monocyte/macrophages transition from a normal 2n chromosome set to a 4n chromosome state. This is consistent with a previous report that describes the transition of the most active macrophages combating Mycobacterium tuberculosis infection to a polyploid state, indicating that 4n transition is a natural mechanism of macrophages during their pathogen response. Polyploidy is not only known to increase resistance to many challenges that would otherwise result in cell death, but also triggers non-linear transcriptomic effects, which disrupt proper cell signaling and we propose are part of the inability of HIV-1 to establish active infection. Non- linear transcriptomic effects become obvious in the comparison of genome-wide transcriptomic signatures (RNA- seq) of different latently HIV- 1 infected monocyte clones, which show extensive inter-clonal heterogeneity. However, despite this extensive transcriptomic heterogeneity, latently HIV-1 infected macrophages share a small common altered biomolecular signature at the transcriptome (RNA-seq) and proteome level (kinome analysis). We identified the phosphatase PPM1A as a key element of this latency control signature. Modulation of PPM1A expression controlled active HIV-1 infection in macrophages, regulated the susceptibility of macrophages to HIV- 1 induced cell death, and altered the capacity of myeloid cells to establish latent infection. Thus targeting PPM1A has the potential to provide a new therapeutic avenue to eradicate HIV-1 reservoirs in macrophages. This application will contribute to our basic molecular understanding of how the intrinsic antiviral response of myeloid cells is controlled and how therapeutic modulation of PPM1A activity could contribute to the elimination of persistent HIV-1 reservoirs in myeloid cells in general and specifically in brain-resident microglia.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OLAF KUTSCH其他文献

OLAF KUTSCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OLAF KUTSCH', 18)}}的其他基金

Loss of Y-chromosome as a driver of HIV-1 latency
Y 染色体丢失是 HIV-1 潜伏期的驱动因素
  • 批准号:
    10882257
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
Control of latent/persistent HIV-1 infection in macrophages/microglia: A key role for the phosphatase PPM1A
控制巨噬细胞/小胶质细胞中潜伏/持续的 HIV-1 感染:磷酸酶 PPM1A 的关键作用
  • 批准号:
    10322277
  • 财政年份:
    2021
  • 资助金额:
    $ 18.56万
  • 项目类别:
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection
诱导潜伏 HIV-1 感染末端转录沉默的药物的鉴定
  • 批准号:
    10223169
  • 财政年份:
    2017
  • 资助金额:
    $ 18.56万
  • 项目类别:
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection
诱导潜伏 HIV-1 感染末端转录沉默的药物的鉴定
  • 批准号:
    10205411
  • 财政年份:
    2017
  • 资助金额:
    $ 18.56万
  • 项目类别:
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells
克服无反应 CD4 T 细胞中的 HIV-1 转录潜伏期
  • 批准号:
    9980780
  • 财政年份:
    2017
  • 资助金额:
    $ 18.56万
  • 项目类别:
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection
诱导潜伏 HIV-1 感染末端转录沉默的药物的鉴定
  • 批准号:
    9393866
  • 财政年份:
    2017
  • 资助金额:
    $ 18.56万
  • 项目类别:
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells
克服无反应 CD4 T 细胞中的 HIV-1 转录潜伏期
  • 批准号:
    9410387
  • 财政年份:
    2017
  • 资助金额:
    $ 18.56万
  • 项目类别:
Kinomic analysis of host cell factors controlling latent HIV-1 infection
控制潜伏 HIV-1 感染的宿主细胞因子的基因组分析
  • 批准号:
    9325418
  • 财政年份:
    2016
  • 资助金额:
    $ 18.56万
  • 项目类别:
Kinomic analysis of host cell factors controlling latent HIV-1 infection
控制潜伏 HIV-1 感染的宿主细胞因子的基因组分析
  • 批准号:
    9292521
  • 财政年份:
    2016
  • 资助金额:
    $ 18.56万
  • 项目类别:
Kinomic analysis of host cell factors controlling latent HIV-1 infection
控制潜伏 HIV-1 感染的宿主细胞因子的基因组分析
  • 批准号:
    8930058
  • 财政年份:
    2014
  • 资助金额:
    $ 18.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了